What protection insurance covers, and where UK policies differ

The Financial Conduct Authority (FCA) published the final report of its Pure Protection Market Study on 21 September 2026 and announced a cross-sector initiative to encourage more people to consider life insurance, critical illness cover and income protection. It is working with the Money and Pensions Service, the Digital Property Market Steering Group, the Protection Distributors' Group, the Association of Mortgage Intermediaries and the Association of British Insurers.

This matters to anyone in the UK with dependants, a mortgage, or an income they could not easily replace if they fell seriously ill. The FCA found that 58% of adults had none of these three products, and that 59% of that group had never considered their protection needs. It also concluded that competition generally delivers good outcomes for people who already hold a policy, with high claims-acceptance rates across the market.

The practical question for a reader is not whether the FCA regulates this market — it does — but which product, if any, matches their circumstances, and what would stop a claim being paid. This explainer sets out what each product does, where they diverge, and why FCA regulation does not guarantee that a policy suits a particular applicant or that a claim will succeed.

What protection insurance means

Pure protection insurance pays financial support if a specified event affects the policyholder or their dependants. It has no savings or investment element: money is paid only if the insured event happens, not built up over time. Life insurance, critical illness cover and income protection are the three main pure-protection products sold to UK retail customers. This is distinct from payment protection insurance, private medical insurance and investment-linked protection, none of which this article covers.

At a glance

Policy wording varies between insurers. This table describes typical structure, not a specific contract.

Life insurance: who it protects and when it pays

Life insurance is designed chiefly to provide money for dependants, or another named recipient, after the insured person dies. It does not itself replace income simply because the insured person becomes ill or unable to work — that is what income protection is for.

Term life insurance pays if the insured person dies during a specified term. Whole-of-life insurance is intended to pay on death whenever it occurs, provided the policy remains in force and its conditions are met. Within term cover, level term keeps the insured amount fixed, decreasing term reduces it over time (commonly aligned with a repayment mortgage), and increasing term raises the benefit, commonly to offset inflation.

Joint life policies commonly pay out once, on the first death, after which cover ends. Two single-life policies can potentially each pay out on their own insured life, subject to each contract's terms.

Critical illness cover: listed conditions, not a general diagnosis

Critical illness cover ordinarily makes one lump-sum payment when the insured person is diagnosed with a condition specifically listed in the policy and meets that policy's definition of it. The policy normally ends once that payment has been made.

The everyday name of an illness does not by itself establish that a policy's contractual definition has been satisfied. Insurers differ in which conditions they list, the severity threshold for each, and whether partial payments apply for less severe or children's conditions. MoneyHelper gives non-invasive cancers, hypertension and broken bones as examples of conditions commonly outside cover, while covered cancers may themselves be limited by type or stage. These are examples, not a universal list — the policy wording controls what is covered.

Income protection: incapacity, not diagnosis

Income protection makes regular payments that replace part of the insured person's earnings when illness or injury leaves them unable to work under the policy's incapacity definition. MoneyHelper describes typical policies as replacing 50% to 65% of income, though the exact proportion, any offset against other income, and the maximum benefit depend on the individual contract.

This is the main structural difference from critical illness cover: income protection responds to an inability to work rather than a diagnosis from a fixed list, and pays an ongoing income rather than a lump sum. The incapacity test matters: an own-occupation test asks whether the person can do their own job, a suited-occupation test whether they can do a job suited to their training, and an any-occupation test whether they can do any job at all. The same condition can meet one definition and fail another.

Payments normally begin only after a deferred period. MoneyHelper lists common periods of 4, 13 and 26 weeks, or one year, often set against how long an employer's sick pay might last. Long-term policies may continue paying until the person returns to work, retires, dies or reaches the end of the policy term, whichever happens first, but some policies limit each claim to a shorter period, so this is worth checking against the specific contract.

Underwriting, disclosure and accurate answers

What a policy costs, and whether it is offered at all, depends on underwriting: the insurer's assessment of the applicant's health, occupation, lifestyle and financial circumstances. Under the Consumer Insurance (Disclosure and Representations) Act 2012, a consumer must take reasonable care not to make a misrepresentation when entering into or varying a consumer insurance contract.

If a misrepresentation later comes to light, the insurer's remedy depends on how it is characterised. For a qualifying careless misrepresentation, the remedy depends on what the insurer would have done had it received accurate information: it may refuse the claim and refund premiums, apply different terms, or reduce the claim proportionately. A deliberate or reckless qualifying misrepresentation can allow the insurer to avoid the contract altogether and refuse all claims. Accuracy on application forms carries real financial consequences later.

Making a claim: why a high acceptance rate is not a guarantee

The FCA's interim report on the pure-protection market recorded that insurers accepted 98% of claims on average in 2024, with £5.3bn paid that year; a later FCA speech instead gave £5.4bn for 2024, and the available source material does not establish which figure is definitive.

A market-wide acceptance rate describes the industry's overall record, not any individual applicant's prospects. A claim is assessed against the specific definitions in the policy sold — the diagnosis criteria for critical illness cover, or the incapacity test for income protection — and the accuracy of answers given at application. The individual contract, not a general guide, determines what happens on a claim, including cover type, deferred period, partial-payment provisions and what happens if premiums lapse.

Why replacing existing cover needs care

Cancelling an existing protection policy to buy a new one can leave a customer worse off, because age and changed health since the original policy started may mean new underwriting produces a higher price, added exclusions, or a refusal to offer equivalent cover. The Financial Ombudsman Service has said a cheaper premium alone is not normally sufficient reason for advice that restricts critical illness cover. The FCA's 2026 work also identified switching as an area needing attention.

What FCA regulation does and does not mean

FCA authorisation concerns a firm's permissions and conduct standards. It does not remove underwriting, exclusions, claim definitions, affordability considerations, or the need to check whether a particular policy matches a particular customer's circumstances.

Where a firm gives advice, FCA rules require that advice to be suitable. Where a sale is non-advised, the customer must be told that they are responsible for deciding whether the policy is suitable for them. Separately, FCA Handbook guidance, in force from 27 July 2026, says a firm should take reasonable steps to ensure a customer buys only a policy under which they are actually eligible to claim benefits.

None of this means every applicant needs a policy, that every applicant will be offered one, or that every claim will satisfy a policy's specific definitions. The FCA's own final report found a large gap between people who might benefit from protection and people who hold it, particularly among renters, self-employed and gig-economy workers, people on lower incomes, and people with pre-existing medical conditions — groups the regulator identifies as disproportionately unprotected, in some cases precisely because underwriting or cost make suitable cover harder to obtain.

Complaints, the Ombudsman and FSCS

If a policyholder disagrees with an insurer's decision, the first step is to complain to the firm itself. An eligible unresolved complaint may then be referred to the Financial Ombudsman Service — a separate route from the Financial Services Compensation Scheme (FSCS), which addresses eligible claims where the insurer itself has failed, rather than disputes over an individual claim decision.

For insurer failures on or after 3 July 2015, the FSCS states that eligible term-life, whole-of-life, critical-illness and income-protection claims are protected at 100% of the valid claim value accepted by the insolvency practitioner. This protects against the insurer's failure — it is not a guarantee that an ordinary, disputed claim would otherwise have succeeded.

What to watch next

The FCA said it is not planning broad new market-wide rules and instead expects to pursue the report's measures through existing frameworks, working with industry from October 2026, with meaningful progress expected within 12 to 18 months. Firms interested in a related protection-gap TechSprint have until 13 November 2026 to express interest, with the event provisionally timed for the third quarter of 2027, subject to sufficient participation. Readers wanting the underlying detail should consult the FCA's published market study directly.